User Name:

Password:

remember me

Forgot your password?

Not a member?

Join Now

News Topic - FDA

RSS feedDisplaying articles 1 - 10 of most recent articles

FDA delayed stronger sunscreens for a decade as melanoma diagnoses spiked A little, hard lump under Cassie Beisels arm in 2011 was her first clue that something was wrong.
nbc4i.com | 17 hours, 12 minutes ago | comment? | recommend article from Columbus, Ohio
Synconas 30m investment pays off FDA approves new diagnostic imaging agent to detect prostate cancer
Financial Times | May 29, 2016 4:11 PM [GMT] | comment? | recommend
Photo from WTOL.com
FDA tweaks nutrition label to highlight sugar content Notable changes include a larger, bolder typeface for servings and calories. Companies are now required to list how much sugar has been added to a product.
WTOL.com | May 28, 2016 7:07 PM [GMT] | comment? | recommend article from Toledo, Ohio
Portola Pharmaceuticals: Does New Data Get It Back on Track? Management presented additional data for its factor Xa anticoagulant that could pave the way to an eventual FDA approval.
Fool.com | May 28, 2016 1:40 PM [GMT] | comment? | recommend
Photo from CNN.com
FDA approves device to wean addicts off heroin The U.S. Food and Drug Administration has approved a drug-emitting implant to combat addiction to heroin and other opioids killing thousands of people annually.
CNN.com | May 28, 2016 12:12 PM [GMT] | comment? | recommend
FDA approves first implant to curb addiction WASHINGTON - Federal health officials on Thursday approved an innovative new option for Americans struggling with addiction to heroin and painkillers: a drug-oozing implant that curbs craving and withdrawal symptoms for six months at a time.
Altoona Mirror | May 28, 2016 04:00 AM [GMT] | comment? | recommend article from Altoona, Pennsylvania
FDA Approves First Implant Treatment For Opioid Addiction An anonymous reader writes from a report via Bloomberg: The Food and Drug Administration cleared the first implant in the U.S. to treat heroin and opioid painkiller addictions. The product, Probuphine, may be used to treat addicts continuously for six mon
Slashdot | May 28, 2016 03:30 AM [GMT] | comment? | recommend
Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA (daclizumab) for Multiple Sclerosis CAMBRIDGE, Mass.and NORTH CHICAGO, Ill., May 27, 2016 /PRNewswire/ --The U.S. Food and Drug Administration (FDA) approved ZINBRYTA™ (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multip
PR Newswire | May 28, 2016 01:38 AM [GMT] | comment? | recommend
Long-Acting Opioid Treatment Could Be Available In A Month The FDA has approved the Probuphine implant for medication-assisted therapy for opioid addiction. It lasts for six months, compared to daily pills. But it also will be more expensive.
NPR.org | May 27, 2016 9:00 PM [GMT] | comment? | recommend
Photo from Mail Online
FDA approves first drug-oozing implant to control addiction The inch-long Probuphine implant, designed to drip feed the drug buprenorphine into the bloodstream over a six-month period to combat opioid and heroin addiction, has been approved by the FDA.
Mail Online | May 27, 2016 7:26 PM [GMT] | comment? | recommend